Shinichiro Hattori Selected Research

GUT-70

2/2015	Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity.
2/2013	Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinichiro Hattori Research Topics

Disease

7	Infections 03/2015 - 01/2008
4	Primary Effusion Lymphoma 12/2014 - 01/2012
3	Neoplasms (Cancer) 02/2016 - 04/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2014
1	Hematologic Neoplasms (Hematological Malignancy) 04/2014
1	Latent Infection 12/2013

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 02/2016 - 01/2008
2	GUT-70IBA 02/2015 - 02/2013
1	Transcription Factors (Transcription Factor)IBA 03/2015
1	CholesterolIBA 12/2014
1	CyclodextrinsIBA 12/2014
1	LipidsIBA 12/2014
1	enhanced green fluorescent proteinIBA 08/2014
1	cepharanthineIBA 05/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2014
1	Oxygen (Dioxygen)IBA 04/2014
1	Sodium Salicylate (Salicylate, Sodium)IBA 04/2014
1	Small Interfering RNA (siRNA)IBA 12/2013
1	Zoledronic Acid (Zometa)FDA Link 05/2013
1	Tumor Biomarkers (Tumor Markers)IBA 01/2012
1	Janus Kinase 3IBA 09/2009
1	islatravirIBA 09/2009
1	Reverse Transcriptase InhibitorsIBA 09/2009
1	NucleosidesIBA 09/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2014
1	Therapeutics 12/2013